Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2016 Filed Feb 23, 2016 23:13 UTC |
YOOR BRIAN BSenior Vice President and CFO
|
GrantOption (right to buy) · Derivative | 213,470 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019929 · edgar.xml · derivative · entry 3 YOOR BRIAN B · CIK 0001643528 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,470 Underlying: Common shares · 213,470 shares Expires 2026-02-18 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 71,157 on 02/19/2017, 71,156 on 02/19/2018, and 71,157 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:13 UTC |
YOOR BRIAN BSenior Vice President and CFO
|
GrantCommon shares without par value | 24,348 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019929 · edgar.xml · nonDerivative · entry 1 YOOR BRIAN B · CIK 0001643528 · Senior Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,090 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:13 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
GrantOption (right to buy) · Derivative | 83,333 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019930 · edgar.xml · derivative · entry 5 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,333 Underlying: Common shares · 83,333 shares Expires 2026-02-18 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,778 on 02/19/2017, 27,777 on 02/19/2018, and 27,778 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:13 UTC |
Funck, Jr. Robert E.Vice President, Controller
|
GrantCommon shares without par value | 9,505 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019930 · edgar.xml · nonDerivative · entry 1 Funck Robert E · CIK 0001565892 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,190 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:13 UTC |
Fussell Stephen RExecutive Vice President
|
GrantOption (right to buy) · Derivative | 313,926 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019931 · edgar.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,926 Underlying: Common shares · 313,926 shares Expires 2026-02-18 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 104,642 on 02/19/2017, 104,642 on 02/19/2018, and 104,642 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:13 UTC |
Fussell Stephen RExecutive Vice President
|
GrantCommon shares without par value | 35,807 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019931 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,408 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 1,198,630 | $0.00 Strike: $38.40 | $0.00 |
DisclosureSEC source: 0001179110-16-019932 · edgar.xml · derivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,198,630 Underlying: Common shares · 1,198,630 shares Expires 2026-02-18 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 399,544 on 02/19/2017, 399,543 on 02/19/2018, and 399,543 on 02/19/2019. Read SEC document |
| February 19, 2016 Filed Feb 23, 2016 23:14 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 136,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-019932 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,530,871 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 16, 2016 Filed Feb 17, 2016 22:44 UTC |
Watkin JaredSenior Vice President
|
SaleCommon shares without par value | 207 | $37.13 | $7,685.91 |
DisclosureSEC source: 0001179110-16-019499 · edgar.xml · nonDerivative · entry 2 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,594 Read SEC document |
| February 16, 2016 Filed Feb 17, 2016 22:56 UTC |
Contreras JaimeSenior Vice President
|
SaleCommon shares without par value | 254 | $37.87 | $9,617.71 |
DisclosureSEC source: 0001179110-16-019501 · edgar.xml · nonDerivative · entry 5 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,694 Read SEC document |
| February 16, 2016 Filed Feb 17, 2016 22:57 UTC |
NATH DEEPAK S.Senior Vice President
|
SaleCommon shares without par value | 171 | $37.13 | $6,349.23 |
DisclosureSEC source: 0001179110-16-019503 · edgar.xml · nonDerivative · entry 2 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,941 Read SEC document |
| February 16, 2016 Filed Feb 17, 2016 22:57 UTC |
Pavee Jean-YvesSenior Vice President
|
SaleCommon shares without par value | 233 | $37.13 | $8,651.29 |
DisclosureSEC source: 0001179110-16-019504 · edgar.xml · nonDerivative · entry 2 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Read SEC document |
| February 15, 2016 Filed Feb 17, 2016 22:44 UTC |
Watkin JaredSenior Vice President
|
Tax withholdingCommon shares without par value | 606 | $37.13 | $22,500.78 |
DisclosureSEC source: 0001179110-16-019499 · edgar.xml · nonDerivative · entry 1 Watkin Jared · CIK 0001645118 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,801 Read SEC document |
| February 15, 2016 Filed Feb 17, 2016 22:56 UTC |
Contreras JaimeSenior Vice President
|
Tax withholdingCommon shares without par value | 146 | $37.13 | $5,420.98 |
DisclosureSEC source: 0001179110-16-019501 · edgar.xml · nonDerivative · entry 4 Contreras Jaime · CIK 0001587070 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 1,948 Read SEC document |
| February 15, 2016 Filed Feb 17, 2016 22:56 UTC |
BIRD ROGERSenior Vice President
|
Tax withholdingCommon shares without par value | 1,131 | $37.13 | $41,994.03 |
DisclosureSEC source: 0001179110-16-019502 · edgar.xml · nonDerivative · entry 1 BIRD ROGER · CIK 0001635313 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,679 Read SEC document |
| February 15, 2016 Filed Feb 17, 2016 22:57 UTC |
NATH DEEPAK S.Senior Vice President
|
Tax withholdingCommon shares without par value | 501 | $37.13 | $18,602.13 |
DisclosureSEC source: 0001179110-16-019503 · edgar.xml · nonDerivative · entry 1 NATH DEEPAK S. · CIK 0001636628 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,112 Read SEC document |
| February 15, 2016 Filed Feb 17, 2016 22:57 UTC |
Pavee Jean-YvesSenior Vice President
|
Tax withholdingCommon shares without par value | 318 | $37.13 | $11,807.34 |
DisclosureSEC source: 0001179110-16-019504 · edgar.xml · nonDerivative · entry 1 Pavee Jean-Yves · CIK 0001580217 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,933 Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 22:05 UTC |
FRINZI THOMAS GSenior Vice President
|
GrantCommon shares without par value | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-017729 · edgar.xml · nonDerivative · entry 1 FRINZI THOMAS G · CIK 0001663458 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 F1 · shares: These shares represent a retention restricted stock award under the Abbott Laboratories 2009 Incentive Stock Program. The award generally vests on the third anniversary of its grant date and includes the right to have shares withheld for tax purposes. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 22:04 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 175 | $44.91 Strike: $0.00 | $7,859.25 |
DisclosureSEC source: 0001179110-16-017076 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,990 Underlying: Common shares · 175 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 22:05 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 768 | $44.91 Strike: $0.00 | $34,490.88 |
DisclosureSEC source: 0001179110-16-017077 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,621 Underlying: Common shares · 768 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 22:06 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 734 | $44.91 Strike: $0.00 | $32,963.94 |
DisclosureSEC source: 0001179110-16-017080 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,413 Underlying: Common shares · 734 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2015 Filed Jan 5, 2016 22:06 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 734 | $44.91 Strike: $0.00 | $32,963.94 |
DisclosureSEC source: 0001179110-16-017083 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,385 Underlying: Common shares · 734 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 438,000 | $0.00 Strike: $21.22 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · derivative · entry 23 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 438,000 shares Expires 2016-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 1,900 | $46.05 | $87,495.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 15 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,153 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 300 | $46.05 | $13,813.50 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 14 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,053 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 1,300 | $46.04 | $59,852.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 13 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,396,353 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 1,100 | $46.04 | $50,638.50 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 12 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,397,653 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 14,439 | $46.03 | $664,627.17 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 11 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,398,753 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 200 | $46.03 | $9,205.50 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 10 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,192 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,617 | $46.03 | $120,447.43 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,413,392 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 12,150 | $46.02 | $559,143.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416,009 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 2,921 | $46.02 | $134,409.82 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,159 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 89,114 | $46.01 | $4,100,135.14 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,431,080 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 400 | $46.01 | $18,403.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520,194 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 14,781 | $46.01 | $679,999.91 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 4 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520,594 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
SaleCommon shares without par value | 296,778 | $46.00 | $13,651,788.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,535,375 Read SEC document |
| December 16, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 438,000 | $21.22 | $9,294,097.20 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,832,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 280 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 22 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 8,832 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 21 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 8,818 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 20 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 0 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 19 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 8,552 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 18 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 8,643 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 630 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 17 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 630 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2015 Filed Dec 18, 2015 22:01 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 76,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016518 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,153 Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 21:07 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 195 | $40.22 Strike: $0.00 | $7,842.90 |
DisclosureSEC source: 0001179110-15-013723 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,789 Underlying: Common shares · 195 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 21:07 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 820 | $40.22 Strike: $0.00 | $32,980.40 |
DisclosureSEC source: 0001179110-15-013724 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,566 Underlying: Common shares · 820 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 21:09 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 820 | $40.22 Strike: $0.00 | $32,980.40 |
DisclosureSEC source: 0001179110-15-013726 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,550 Underlying: Common shares · 820 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2015 Filed Oct 2, 2015 21:09 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 857 | $40.22 Strike: $0.00 | $34,468.54 |
DisclosureSEC source: 0001179110-15-013725 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,734 Underlying: Common shares · 857 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 28, 2015 Filed Sep 29, 2015 21:36 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
SaleCommon shares without par value | 715 | $39.65 | $28,347.61 |
DisclosureSEC source: 0001179110-15-013392 · edgar.xml · nonDerivative · entry 3 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,974 Read SEC document |
| September 28, 2015 Filed Sep 29, 2015 21:36 UTC |
Salvadori Daniel Gesua SiveSenior Vice President
|
SaleCommon shares without par value | 100 | $39.64 | $3,964.10 |
DisclosureSEC source: 0001179110-15-013392 · edgar.xml · nonDerivative · entry 2 Salvadori Daniel Gesua Sive · CIK 0001620564 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,689 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.